IShares IBonds Financial Statements From 2010 to 2024
| IBHG Etf | USD 22.54 0.03 0.13% |
Check IShares IBonds financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among IShares IBonds' main balance sheet or income statement drivers, such as , as well as many indicators such as . IShares financial statements analysis is a perfect complement when working with IShares IBonds Valuation or Volatility modules.
IShares |
iShares iBonds 2027 ETF Beta Analysis
IShares IBonds' Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current IShares IBonds Beta | 0.76 |
Most of IShares IBonds' fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, iShares iBonds 2027 is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, iShares iBonds 2027 has a Beta of 0.76. This is much higher than that of the iShares family and significantly higher than that of the High Yield Bond category. The beta for all United States etfs is notably lower than that of the firm.
About IShares IBonds Financial Statements
IShares IBonds stakeholders use historical fundamental indicators, such as IShares IBonds' revenue or net income, to determine how well the company is positioned to perform in the future. Although IShares IBonds investors may analyze each financial statement separately, they are all interrelated. For example, changes in IShares IBonds' assets and liabilities are reflected in the revenues and expenses on IShares IBonds' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in iShares iBonds 2027. Please read more on our technical analysis and fundamental analysis pages.
The index is composed of U.S. dollar-denominated, taxable, fixed-rate, high yield and BBB or equivalently rated corporate bonds scheduled to mature between January 1, 2027 and December 15, 2027, inclusive. Ishares Ibonds is traded on BATS Exchange in the United States.
Currently Active Assets on Macroaxis
When determining whether iShares iBonds 2027 is a strong investment it is important to analyze IShares IBonds' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact IShares IBonds' future performance. For an informed investment choice regarding IShares Etf, refer to the following important reports:Check out the analysis of IShares IBonds Correlation against competitors. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
The market value of iShares iBonds 2027 is measured differently than its book value, which is the value of IShares that is recorded on the company's balance sheet. Investors also form their own opinion of IShares IBonds' value that differs from its market value or its book value, called intrinsic value, which is IShares IBonds' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IShares IBonds' market value can be influenced by many factors that don't directly affect IShares IBonds' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IShares IBonds' value and its price as these two are different measures arrived at by different means. Investors typically determine if IShares IBonds is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IShares IBonds' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.